Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms

Expert Opinion on Pharmacotherapy
Jeffrey T Jensen, David F Archer

Abstract

Considerable recent interest has focused on new methods of delivery of oral contraceptives that reduce or eliminate the hormone-free interval in order to improve convenience and acceptability, but maintain contraceptive efficacy, minimize side effects and reduce or eliminate the frequency of withdrawal bleeding episodes. Studies in several countries, including the US, have documented that many women would prefer to have no episodes of withdrawal bleeding when using oral contraceptives. This review focuses on a unique oral contraceptive formulation containing levonogestrel 90 microg and ethinyl estradiol 20 microg, approved for use in a continuous dosing regimen designed to eliminate withdrawal bleeding throughout the entire year.

References

Feb 1, 1992·American Journal of Obstetrics and Gynecology·J C RobinsonM Ensminger
Mar 1, 1992·American Journal of Obstetrics and Gynecology·S F LanesS Singer
Jun 1, 1991·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·E M Belsey
Jun 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·K Fotherby
May 1, 1989·American Journal of Obstetrics and Gynecology·J W Goldzieher
Jul 13, 1984·The American Journal of Medicine·M Y Dawood
Sep 1, 1995·Contraception·M J RosenbergP J Hillard
Mar 1, 1995·Clinical Pharmacokinetics·K Fotherby
Jun 4, 1998·Obstetrics and Gynecology·K M CurtisH B Peterson
Feb 13, 1999·American Journal of Obstetrics and Gynecology·M Rosenberg, M S Waugh
Nov 16, 1999·American Journal of Obstetrics and Gynecology·R RiveraD Grimes
Jan 29, 2000·BMJ : British Medical Journal·J ShakespeareK Hodder
Feb 16, 2000·Obstetrics and Gynecology·P J SulakT J Kuehl
Nov 25, 2000·Obstetrics and Gynecology Clinics of North America·J T Jensen, L Speroff
Mar 10, 2001·Contraception·A M Kaunitz
Jul 13, 2001·Menopause : the Journal of the North American Menopause Society·D F Archer
Jun 18, 2002·American Journal of Obstetrics and Gynecology·Patricia J SulakBobby L Shull
Aug 31, 2002·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·J EndrikatW Kuhnz
Dec 5, 2002·Cancer Causes & Control : CCC·Juliet V PorchJulie E Burin
Apr 10, 2003·Obstetrics and Gynecology·Leslie Miller, James P Hughes
Sep 5, 2003·Contraception·F D Anderson, Howard Hait
Nov 17, 2004·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Sirkku VuormaPekka Rissanen
Jan 12, 2005·Journal of Occupational and Environmental Medicine·Jeff BorensteinSally Wade
Mar 2, 2006·Obstetrics and Gynecology·Alison B EdelmanJeffrey T Jensen
Dec 13, 2006·Contraception·David F ArcherGinger D Constantine
Apr 17, 2007·Contraception·Emily Shortridge, Kate Miller

❮ Previous
Next ❯

Citations

May 12, 2011·Reviews in Endocrine & Metabolic Disorders·Jeffrey T Jensen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.